|July 2007 (Volume 14, Issue 7)
Article 513: Radiant Research Leads Global Change in Site Management Market
- Radiant Research has claimed profitability nearly every year since it was founded in 1998. The company has grown not only through a series of acquisitions, but also by expanding existing facilities and opening new centers. Radiant is embarking on a new global growth period with the backing of a private equity group, which took ownership in June. Radiant, which has trimmed itself down to 26 owned sites, plans to take its SMO model worldwide. Other SMOs, of varying models, continue to be successful, following the niches slide when many SMOs exited the market.
Article 514: Positive Volunteer Experience Holds Steady in New CenterWatch Study
- More than 90% of study volunteers say their experiences were good enough in a clinical trial that they would participate again. Despite all of the bad press about the pharmaceutical industry, study volunteers remain steadfast in their support of trial participation. CenterWatch surveyed 620 study volunteers across the United States in April and May 2007 on issues such as how they learned about the study, which factors influenced their decision to participate, and how well they understood study expectations. More than half of respondents had participated in a study this year or in 2006.
Article 515: German Research Down But Far From Out
- Germany has been struggling in the increasingly global clinical trials industry.
Article 516: Eye On Leukemia
- Respiratory diseases encompass a broad spectrum of pathology including chronic obstructivepulmonary disease (COPD), asthma,and other conditions characterized by airway blockage or narrowing; restrictive lung diseases such as idiopathic pulmonary fibrosis; and a host of infections acquired both in the community and in the hospital.